Pulmatrix Free Cash Flow (FCF) History (PULM)
Pulmatrix reported −$11.1M in free cash flow for fiscal 2024, an increase of $5.5M from the previous fiscal year, with a free cash flow margin of −142.38%.
View full Pulmatrix company overviewPulmatrix free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$11.1M | $5.5M | — | −142.38% |
| 2023 | 2023-12-31 | −$16.7M | $2.8M | — | −228.30% |
| 2022 | 2022-12-31 | −$19.4M | $429,000 | — | −320.24% |
| 2021 | 2021-12-31 | −$19.9M | −$7.1M | — | −384.43% |
| 2020 | 2020-12-31 | −$12.8M | −$15.9M | — | −101.03% |
| 2019 | 2019-12-31 | $3.2M | $20.0M | — | +40.10% |
| 2018 | 2018-12-31 | −$16.8M | −$2.2M | — | −10967.32% |
| 2017 | 2017-12-31 | −$14.6M | −$853,000 | — | −4343.58% |
| 2016 | 2016-12-31 | −$13.7M | −$960,000 | — | −1640.48% |
| 2015 · Dec 31 | 2015-12-31 | −$12.7M | −$7.2M | — | −1060.62% |
| 2015 · Mar 31 | 2015-03-31 | −$5.5M | $3.9M | — | — |
| 2014 · Dec 31 | 2014-12-31 | −$9.5M | −$6.5M | — | −2684.94% |
| 2014 · Mar 31 | 2014-03-31 | −$3.0M | — | — | — |
Pulmatrix quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$1.3M | $3.2M | — | −42033.33% |
| Q3 2024 | 2024-09-30 | −$3.1M | $2.0M | — | −835.79% |
| Q2 2024 | 2024-06-30 | −$3.9M | −$317,000 | — | −252.64% |
| Q1 2024 | 2024-03-31 | −$2.9M | $1.8M | — | −48.82% |
| Q3 2023 | 2023-09-30 | −$4.5M | $1.7M | — | −254.14% |
| Q4 2022 | 2022-12-31 | −$5.1M | −$1.6M | — | −295.96% |
| Q3 2022 | 2022-09-30 | −$3.6M | −$753,000 | — | −192.52% |
| Q2 2022 | 2022-06-30 | −$4.6M | $986,000 | — | −347.78% |
| Q1 2022 | 2022-03-31 | −$6.2M | −$1.2M | — | −530.52% |
| Q3 2021 | 2021-09-30 | −$3.4M | −$4.1M | — | −319.18% |
| Q4 2020 | 2020-12-31 | −$2.9M | $1.6M | — | −142.55% |
| Q3 2020 | 2020-09-30 | −$5.6M | −$1.7M | — | −128.43% |
| Q2 2020 | 2020-06-30 | −$5.0M | −$20.0M | — | −142.86% |
| Q1 2020 | 2020-03-31 | $702,000 | $4.2M | — | +25.42% |
| Q4 2019 | 2019-12-31 | −$4.4M | $85,000 | — | — |
| Q3 2019 | 2019-09-30 | −$3.9M | $697,000 | — | −280.37% |
| Q2 2019 | 2019-06-30 | $15.0M | $17.5M | — | +311.72% |
| Q1 2019 | 2019-03-31 | −$3.5M | −$403,000 | — | — |
| Q3 2018 | 2018-09-30 | −$4.5M | −$562,000 | — | — |
| Q3 2017 | 2017-09-30 | −$4.6M | −$490,000 | — | −1384.78% |
| Q4 2016 | 2016-12-31 | −$2.5M | $603,000 | — | −2136.44% |
| Q3 2016 | 2016-09-30 | −$3.1M | $419,000 | — | −5021.31% |
| Q2 2016 · Jun 30 | 2016-06-30 | −$4.0M | −$4,000 | — | −1525.00% |
| Q1 2016 · Mar 31 | 2016-03-31 | −$4.1M | −$2.0M | — | −1047.73% |
| Q4 2015 | 2015-12-31 | −$3.1M | −$1.8M | — | −1136.00% |
| Q2 2016 · Sep 30 | 2015-09-30 | −$3.5M | −$2.1M | — | −534.87% |
| Q1 2016 · Jun 30 | 2015-06-30 | −$4.0M | −$2.3M | — | −2330.00% |
| Q4 2015 | 2015-03-31 | −$2.2M | −$1.1M | — | −2067.62% |
| Q4 2014 | 2014-12-31 | −$1.3M | −$980,000 | — | — |
| Q2 2015 | 2014-09-30 | −$1.4M | — | — | −4606.67% |
| Q1 2015 | 2014-06-30 | −$1.6M | — | — | — |
| Q2 2014 | 2013-09-30 | −$1.0M | — | — | — |
| Q1 2014 | 2013-06-30 | −$329,000 | — | — | — |
Pulmatrix free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $3.2M to −$11.1M, a net decrease of $14.3M. Pulmatrix's latest reported quarter, Q4 2024, generated −$1.3M in free cash flow, an increase of $3.2M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pulmatrix filings at SEC.gov ↗